Global MET Inhibitor Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global MET Inhibitor Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for MET Inhibitor Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for MET Inhibitor Drugs by Country/Region, 2017, 2022 & 2028

2.2 MET Inhibitor Drugs Segment by Type

2.2.1 C-Met Biological Inhibitors

2.2.2 Small Molecule C-Met Inhibitors

2.2.3 C-Met Antagonist Antibodies

2.2.4 HGF Antagonist Antibodies

2.2.5 Kringle Variant Antagonists

2.3 MET Inhibitor Drugs Sales by Type

2.3.1 Global MET Inhibitor Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global MET Inhibitor Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global MET Inhibitor Drugs Sale Price by Type (2017-2022)

2.4 MET Inhibitor Drugs Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Others

2.5 MET Inhibitor Drugs Sales by Application

2.5.1 Global MET Inhibitor Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global MET Inhibitor Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global MET Inhibitor Drugs Sale Price by Application (2017-2022)

3 Global MET Inhibitor Drugs by Company

3.1 Global MET Inhibitor Drugs Breakdown Data by Company

3.1.1 Global MET Inhibitor Drugs Annual Sales by Company (2020-2022)

3.1.2 Global MET Inhibitor Drugs Sales Market Share by Company (2020-2022)

3.2 Global MET Inhibitor Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global MET Inhibitor Drugs Revenue by Company (2020-2022)

3.2.2 Global MET Inhibitor Drugs Revenue Market Share by Company (2020-2022)

3.3 Global MET Inhibitor Drugs Sale Price by Company

3.4 Key Manufacturers MET Inhibitor Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers MET Inhibitor Drugs Product Location Distribution

3.4.2 Players MET Inhibitor Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for MET Inhibitor Drugs by Geographic Region

4.1 World Historic MET Inhibitor Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global MET Inhibitor Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global MET Inhibitor Drugs Annual Revenue by Geographic Region

4.2 World Historic MET Inhibitor Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global MET Inhibitor Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global MET Inhibitor Drugs Annual Revenue by Country/Region

4.3 Americas MET Inhibitor Drugs Sales Growth

4.4 APAC MET Inhibitor Drugs Sales Growth

4.5 Europe MET Inhibitor Drugs Sales Growth

4.6 Middle East & Africa MET Inhibitor Drugs Sales Growth

5 Americas

5.1 Americas MET Inhibitor Drugs Sales by Country

5.1.1 Americas MET Inhibitor Drugs Sales by Country (2017-2022)

5.1.2 Americas MET Inhibitor Drugs Revenue by Country (2017-2022)

5.2 Americas MET Inhibitor Drugs Sales by Type

5.3 Americas MET Inhibitor Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC MET Inhibitor Drugs Sales by Region

6.1.1 APAC MET Inhibitor Drugs Sales by Region (2017-2022)

6.1.2 APAC MET Inhibitor Drugs Revenue by Region (2017-2022)

6.2 APAC MET Inhibitor Drugs Sales by Type

6.3 APAC MET Inhibitor Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe MET Inhibitor Drugs by Country

7.1.1 Europe MET Inhibitor Drugs Sales by Country (2017-2022)

7.1.2 Europe MET Inhibitor Drugs Revenue by Country (2017-2022)

7.2 Europe MET Inhibitor Drugs Sales by Type

7.3 Europe MET Inhibitor Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa MET Inhibitor Drugs by Country

8.1.1 Middle East & Africa MET Inhibitor Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa MET Inhibitor Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa MET Inhibitor Drugs Sales by Type

8.3 Middle East & Africa MET Inhibitor Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of MET Inhibitor Drugs

10.3 Manufacturing Process Analysis of MET Inhibitor Drugs

10.4 Industry Chain Structure of MET Inhibitor Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 MET Inhibitor Drugs Distributors

11.3 MET Inhibitor Drugs Customer

12 World Forecast Review for MET Inhibitor Drugs by Geographic Region

12.1 Global MET Inhibitor Drugs Market Size Forecast by Region

12.1.1 Global MET Inhibitor Drugs Forecast by Region (2023-2028)

12.1.2 Global MET Inhibitor Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global MET Inhibitor Drugs Forecast by Type

12.7 Global MET Inhibitor Drugs Forecast by Application

13 Key Players Analysis

13.1 Abbott Laboratories

13.1.1 Abbott Laboratories Company Information

13.1.2 Abbott Laboratories MET Inhibitor Drugs Product Offered

13.1.3 Abbott Laboratories MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Laboratories Main Business Overview

13.1.5 Abbott Laboratories Latest Developments

13.2 Johnson and Johnson

13.2.1 Johnson and Johnson Company Information

13.2.2 Johnson and Johnson MET Inhibitor Drugs Product Offered

13.2.3 Johnson and Johnson MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson and Johnson Main Business Overview

13.2.5 Johnson and Johnson Latest Developments

13.3 Novartis International AG

13.3.1 Novartis International AG Company Information

13.3.2 Novartis International AG MET Inhibitor Drugs Product Offered

13.3.3 Novartis International AG MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novartis International AG Main Business Overview

13.3.5 Novartis International AG Latest Developments

13.4 Eli Lilly and Company

13.4.1 Eli Lilly and Company Company Information

13.4.2 Eli Lilly and Company MET Inhibitor Drugs Product Offered

13.4.3 Eli Lilly and Company MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eli Lilly and Company Main Business Overview

13.4.5 Eli Lilly and Company Latest Developments

13.5 Pfizer Inc., Merck & Co.

13.5.1 Pfizer Inc., Merck & Co. Company Information

13.5.2 Pfizer Inc., Merck & Co. MET Inhibitor Drugs Product Offered

13.5.3 Pfizer Inc., Merck & Co. MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Inc., Merck & Co. Main Business Overview

13.5.5 Pfizer Inc., Merck & Co. Latest Developments

13.6 Takeda Pharmaceutical Company

13.6.1 Takeda Pharmaceutical Company Company Information

13.6.2 Takeda Pharmaceutical Company MET Inhibitor Drugs Product Offered

13.6.3 Takeda Pharmaceutical Company MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Takeda Pharmaceutical Company Main Business Overview

13.6.5 Takeda Pharmaceutical Company Latest Developments

13.7 GlaxosmithKline plc

13.7.1 GlaxosmithKline plc Company Information

13.7.2 GlaxosmithKline plc MET Inhibitor Drugs Product Offered

13.7.3 GlaxosmithKline plc MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GlaxosmithKline plc Main Business Overview

13.7.5 GlaxosmithKline plc Latest Developments

13.8 Amgen Inc.

13.8.1 Amgen Inc. Company Information

13.8.2 Amgen Inc. MET Inhibitor Drugs Product Offered

13.8.3 Amgen Inc. MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Amgen Inc. Main Business Overview

13.8.5 Amgen Inc. Latest Developments

13.9 Bristol Myers Squibb

13.9.1 Bristol Myers Squibb Company Information

13.9.2 Bristol Myers Squibb MET Inhibitor Drugs Product Offered

13.9.3 Bristol Myers Squibb MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bristol Myers Squibb Main Business Overview

13.9.5 Bristol Myers Squibb Latest Developments

13.10 Daiichi Sankyo Company, Limited

13.10.1 Daiichi Sankyo Company, Limited Company Information

13.10.2 Daiichi Sankyo Company, Limited MET Inhibitor Drugs Product Offered

13.10.3 Daiichi Sankyo Company, Limited MET Inhibitor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Daiichi Sankyo Company, Limited Main Business Overview

13.10.5 Daiichi Sankyo Company, Limited Latest Developments

14 Research Findings and Conclusion

Table 1. MET Inhibitor Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. MET Inhibitor Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of C-Met Biological Inhibitors

Table 4. Major Players of Small Molecule C-Met Inhibitors

Table 5. Major Players of C-Met Antagonist Antibodies

Table 6. Major Players of HGF Antagonist Antibodies

Table 7. Major Players of Kringle Variant Antagonists

Table 8. Global MET Inhibitor Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global MET Inhibitor Drugs Sales Market Share by Type (2017-2022)

Table 10. Global MET Inhibitor Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global MET Inhibitor Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global MET Inhibitor Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global MET Inhibitor Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global MET Inhibitor Drugs Sales Market Share by Application (2017-2022)

Table 15. Global MET Inhibitor Drugs Revenue by Application (2017-2022)

Table 16. Global MET Inhibitor Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global MET Inhibitor Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global MET Inhibitor Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global MET Inhibitor Drugs Sales Market Share by Company (2020-2022)

Table 20. Global MET Inhibitor Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global MET Inhibitor Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global MET Inhibitor Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers MET Inhibitor Drugs Producing Area Distribution and Sales Area

Table 24. Players MET Inhibitor Drugs Products Offered

Table 25. MET Inhibitor Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global MET Inhibitor Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global MET Inhibitor Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global MET Inhibitor Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global MET Inhibitor Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global MET Inhibitor Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global MET Inhibitor Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global MET Inhibitor Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global MET Inhibitor Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas MET Inhibitor Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas MET Inhibitor Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas MET Inhibitor Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas MET Inhibitor Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas MET Inhibitor Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas MET Inhibitor Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas MET Inhibitor Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas MET Inhibitor Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC MET Inhibitor Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC MET Inhibitor Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC MET Inhibitor Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC MET Inhibitor Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC MET Inhibitor Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC MET Inhibitor Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC MET Inhibitor Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC MET Inhibitor Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe MET Inhibitor Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe MET Inhibitor Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe MET Inhibitor Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe MET Inhibitor Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe MET Inhibitor Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe MET Inhibitor Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe MET Inhibitor Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe MET Inhibitor Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa MET Inhibitor Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa MET Inhibitor Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa MET Inhibitor Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa MET Inhibitor Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa MET Inhibitor Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa MET Inhibitor Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa MET Inhibitor Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa MET Inhibitor Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of MET Inhibitor Drugs

Table 69. Key Market Challenges & Risks of MET Inhibitor Drugs

Table 70. Key Industry Trends of MET Inhibitor Drugs

Table 71. MET Inhibitor Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. MET Inhibitor Drugs Distributors List

Table 74. MET Inhibitor Drugs Customer List

Table 75. Global MET Inhibitor Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global MET Inhibitor Drugs Sales Market Forecast by Region

Table 77. Global MET Inhibitor Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global MET Inhibitor Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas MET Inhibitor Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas MET Inhibitor Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC MET Inhibitor Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC MET Inhibitor Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe MET Inhibitor Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe MET Inhibitor Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa MET Inhibitor Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa MET Inhibitor Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global MET Inhibitor Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global MET Inhibitor Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global MET Inhibitor Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global MET Inhibitor Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global MET Inhibitor Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global MET Inhibitor Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global MET Inhibitor Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global MET Inhibitor Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Abbott Laboratories Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Abbott Laboratories MET Inhibitor Drugs Product Offered

Table 97. Abbott Laboratories MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Abbott Laboratories Main Business

Table 99. Abbott Laboratories Latest Developments

Table 100. Johnson and Johnson Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Johnson and Johnson MET Inhibitor Drugs Product Offered

Table 102. Johnson and Johnson MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. Johnson and Johnson Main Business

Table 104. Johnson and Johnson Latest Developments

Table 105. Novartis International AG Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Novartis International AG MET Inhibitor Drugs Product Offered

Table 107. Novartis International AG MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Novartis International AG Main Business

Table 109. Novartis International AG Latest Developments

Table 110. Eli Lilly and Company Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Eli Lilly and Company MET Inhibitor Drugs Product Offered

Table 112. Eli Lilly and Company MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Eli Lilly and Company Main Business

Table 114. Eli Lilly and Company Latest Developments

Table 115. Pfizer Inc., Merck & Co. Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Pfizer Inc., Merck & Co. MET Inhibitor Drugs Product Offered

Table 117. Pfizer Inc., Merck & Co. MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. Pfizer Inc., Merck & Co. Main Business

Table 119. Pfizer Inc., Merck & Co. Latest Developments

Table 120. Takeda Pharmaceutical Company Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Takeda Pharmaceutical Company MET Inhibitor Drugs Product Offered

Table 122. Takeda Pharmaceutical Company MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Takeda Pharmaceutical Company Main Business

Table 124. Takeda Pharmaceutical Company Latest Developments

Table 125. GlaxosmithKline plc Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. GlaxosmithKline plc MET Inhibitor Drugs Product Offered

Table 127. GlaxosmithKline plc MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. GlaxosmithKline plc Main Business

Table 129. GlaxosmithKline plc Latest Developments

Table 130. Amgen Inc. Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Amgen Inc. MET Inhibitor Drugs Product Offered

Table 132. Amgen Inc. MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Amgen Inc. Main Business

Table 134. Amgen Inc. Latest Developments

Table 135. Bristol Myers Squibb Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Bristol Myers Squibb MET Inhibitor Drugs Product Offered

Table 137. Bristol Myers Squibb MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Bristol Myers Squibb Main Business

Table 139. Bristol Myers Squibb Latest Developments

Table 140. Daiichi Sankyo Company, Limited Basic Information, MET Inhibitor Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. Daiichi Sankyo Company, Limited MET Inhibitor Drugs Product Offered

Table 142. Daiichi Sankyo Company, Limited MET Inhibitor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Daiichi Sankyo Company, Limited Main Business

Table 144. Daiichi Sankyo Company, Limited Latest Developments

List of Figures

Figure 1. Picture of MET Inhibitor Drugs

Figure 2. MET Inhibitor Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global MET Inhibitor Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global MET Inhibitor Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. MET Inhibitor Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of C-Met Biological Inhibitors

Figure 10. Product Picture of Small Molecule C-Met Inhibitors

Figure 11. Product Picture of C-Met Antagonist Antibodies

Figure 12. Product Picture of HGF Antagonist Antibodies

Figure 13. Product Picture of Kringle Variant Antagonists

Figure 14. Global MET Inhibitor Drugs Sales Market Share by Type in 2021

Figure 15. Global MET Inhibitor Drugs Revenue Market Share by Type (2017-2022)

Figure 16. MET Inhibitor Drugs Consumed in Hospital Pharmacies

Figure 17. Global MET Inhibitor Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 18. MET Inhibitor Drugs Consumed in Retail Pharmacies

Figure 19. Global MET Inhibitor Drugs Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 20. MET Inhibitor Drugs Consumed in Others

Figure 21. Global MET Inhibitor Drugs Market: Others (2017-2022) & (K Units)

Figure 22. Global MET Inhibitor Drugs Sales Market Share by Application (2017-2022)

Figure 23. Global MET Inhibitor Drugs Revenue Market Share by Application in 2021

Figure 24. MET Inhibitor Drugs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global MET Inhibitor Drugs Revenue Market Share by Company in 2021

Figure 26. Global MET Inhibitor Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global MET Inhibitor Drugs Revenue Market Share by Geographic Region in 2021

Figure 28. Global MET Inhibitor Drugs Sales Market Share by Region (2017-2022)

Figure 29. Global MET Inhibitor Drugs Revenue Market Share by Country/Region in 2021

Figure 30. Americas MET Inhibitor Drugs Sales 2017-2022 (K Units)

Figure 31. Americas MET Inhibitor Drugs Revenue 2017-2022 ($ Millions)

Figure 32. APAC MET Inhibitor Drugs Sales 2017-2022 (K Units)

Figure 33. APAC MET Inhibitor Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Europe MET Inhibitor Drugs Sales 2017-2022 (K Units)

Figure 35. Europe MET Inhibitor Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa MET Inhibitor Drugs Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa MET Inhibitor Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Americas MET Inhibitor Drugs Sales Market Share by Country in 2021

Figure 39. Americas MET Inhibitor Drugs Revenue Market Share by Country in 2021

Figure 40. United States MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC MET Inhibitor Drugs Sales Market Share by Region in 2021

Figure 45. APAC MET Inhibitor Drugs Revenue Market Share by Regions in 2021

Figure 46. China MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe MET Inhibitor Drugs Sales Market Share by Country in 2021

Figure 53. Europe MET Inhibitor Drugs Revenue Market Share by Country in 2021

Figure 54. Germany MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa MET Inhibitor Drugs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa MET Inhibitor Drugs Revenue Market Share by Country in 2021

Figure 61. Egypt MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country MET Inhibitor Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of MET Inhibitor Drugs in 2021

Figure 67. Manufacturing Process Analysis of MET Inhibitor Drugs

Figure 68. Industry Chain Structure of MET Inhibitor Drugs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles